Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small nuclear ribonucleoprotein polypeptide F pseudogene 3 (SNRPFP3) is a human pseudogene related to the small nuclear ribonucleoprotein polypeptide F gene. Pseudogenes like SNRPFP3 arise from duplication or retrotransposition of ancestral genes and typically lack the ability to encode functional proteins due to accumulated mutations, truncation, or lack of regulatory sequences[1][3]. While some pseudogenes can produce non-coding RNAs that modulate gene expression (e.g., via competitive endogenous RNA mechanisms or miRNA sponging), there is no evidence that SNRPFP3 is actively transcribed or has any biological function or disease relevance. It is not considered a valid therapeutic target or biomarker, and there are no drugs known to interact with it[1][2][3]. Where relevant, pseudogenes may affect biological pathways by competing for regulatory RNAs with their parent gene; however, this function has been observed in only a small subset of pseudogenes and is not established for SNRPFP3[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nuclear ribonucleoprotein polypeptide F pseudogene 3 (SNRPFP3).